Search research articles
Contact Us
Filters
Showing results (251-260 of 276) with videos related to
Page
of 28
Sort By:
Oncotarget
|
November 19, 2016
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis
Mehmet Asim Bilen, Kenneth R Hess, Matthew T Campbell, et al.
Journal for Immunotherapy of Cancer
|
July 30, 2021
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, et al.
Clinical Genitourinary Cancer
|
July 18, 2020
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer
Nicholas Spetsieris, Myrto Boukovala, Justin A Weldon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma
Ying C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
American Journal of Human Genetics
|
March 8, 2024
Tissue- and cell-type-specific molecular and functional signatures of 16p11.2 reciprocal genomic disorder across mouse brain and human neuronal models
Derek J C Tai, Parisa Razaz, Serkan Erdin, et al.
American Journal of Human Genetics
|
September 24, 2022
Tissue- and cell-type-specific molecular and functional signatures of 16p11.2 reciprocal genomic disorder across mouse brain and human neuronal models
Derek J C Tai, Parisa Razaz, Serkan Erdin, et al.
European Urology Oncology
|
November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
Omar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
JAMA Oncology
|
April 6, 2023
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial
Chad Tang, Alexander D Sherry, Cara Haymaker, et al.
Science Translational Medicine
|
January 3, 2024
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates
Madhu Prabhakaran, Flavio Matassoli, David Leggat, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 276) with videos related to
Sort By:
Page
of 28
Oncotarget
|
November 19, 2016
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis
Mehmet Asim Bilen, Kenneth R Hess, Matthew T Campbell, et al.
Journal for Immunotherapy of Cancer
|
July 30, 2021
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, et al.
Clinical Genitourinary Cancer
|
July 18, 2020
A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer
Nicholas Spetsieris, Myrto Boukovala, Justin A Weldon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma
Ying C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
American Journal of Human Genetics
|
March 8, 2024
Tissue- and cell-type-specific molecular and functional signatures of 16p11.2 reciprocal genomic disorder across mouse brain and human neuronal models
Derek J C Tai, Parisa Razaz, Serkan Erdin, et al.
American Journal of Human Genetics
|
September 24, 2022
Tissue- and cell-type-specific molecular and functional signatures of 16p11.2 reciprocal genomic disorder across mouse brain and human neuronal models
Derek J C Tai, Parisa Razaz, Serkan Erdin, et al.
European Urology Oncology
|
November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
Omar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
JAMA Oncology
|
April 6, 2023
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial
Chad Tang, Alexander D Sherry, Cara Haymaker, et al.
Science Translational Medicine
|
January 3, 2024
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates
Madhu Prabhakaran, Flavio Matassoli, David Leggat, et al.
Page
of 28